More than 100 cars lined the streets of Newport today as the community came together to honour the life of Mikey, a beloved young man whose courage and spirit touched everyone who knew him.

Mikey, who lived with Duchenne muscular dystrophy, passed away earlier this month at the age of 21. His funeral, held at ...

Sarepta Therapeutics obtained traditional FDA approval for ambulatory DMD patients and accelerated approval for ...

Sarcomatrix Therapeutics, a biopharmaceutical company developing small‑molecule treatments for Duchenne muscular dystrophy (DMD), today announced it has received a $300,000 investment from Nevada’s ...

This weekend, the Rockford community will come together once again for the 27th Annual Mitchell's Run Thru Rockford (MRTR), a USATF-certified 5K run/walk and Kids K benefiting Parent Project Muscular ...

Echocardiography may be at the vanguard for early and rapid detection of heart issues indicative of Duchenne muscular ...

US FDA grants orphan drug designation to Keros Therapeutics’ KER-065 to treat Duchenne muscular dystrophy: Lexington, Massachusetts Friday, August 22, 2025, 15:00 Hrs [IST] Kero ...

The FDA’s shift on Elevidys sends a message: boldness, scientific rigor and urgency are essential in confronting rare ...

Discover the challenges and opportunities for Keros Therapeutics, Inc., including FDA designations, partnerships, and ...

Certain Sarepta Therapeutics Inc. insiders were accused in a stockholder lawsuit of reaping a combined $6.2 million selling ...